Stay updated with the latest developments in HeartSciences AI-ECG technology, partnerships, and company announcements.
"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nCEO Andrew Simpson Discusses HeartSciences’ AI-ECG Solutions \nApril 14, 2025\n\nHeartSciences’ CEO Andrew Simpson discusses heart disease and our...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\n6 Modern Cardiac Technologies for Heart Monitoring\nApril 7, 2025\n\nMyoVista integrates SCG with ECG to provide both mechanical and electrical in...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nBig Biz Show – HeartSciences CEO Andrew discusses MyoVista wavECG & MyoVista Insights Cloud Platform\nNovember 14, 2024\n\nHeartSciences is develo...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nPart 1 – Big Biz Show TV Interview with HeartSciences (HSCS) CEO Andrew Simpson\nFebruary 10, 2023\n\nWe’re working to change what’s possible with...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nCEO Andrew Simpson at the RHK 2022 Disruptive Growth Conference on Monday December 5 in NYC\nDecember 5, 2022\n\nSee the original video via Twitte...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nCEO Andrew Simpson discusses how we’re one of the only companies leading the use of an AI-enabled EKG medical device to make it a far more valuabl...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nCEO Andrew Simpson on what’s ahead and how we’re applying advanced science and artificial intelligence to the ECG to make it a much more valuable ...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nChairman & CEO, Andrew Simpson, Describes AI-based Technology EKG Test and Next Steps for Commercialization\nOctober 19, 2022\n\nChairman & CEO, A...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nCibolo Health Designates HeartSciences’ MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals\nJanuary 2...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nData generated by our AI-based technology has been peer reviewed in several prominent medical journals, including JACC Journals and ESC Journals .
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nDo you think home devices like the Apple Watch are going to eat into our potential marketshare? Think again.
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nEXCLUSIVE: HeartSciences Announces Expansion of Artificial Intelligence Patent Portfolio\nAugust 17, 2023\n\nhttp://EXCLUSIVE: HeartSciences Annou...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nFoundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences’ Patent Portfolio and IP Value\nJune 3, 2025\n\...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHonored to attend a global discussion on AI as part of the UN General Assembly in New York City!
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nH.C.
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHear from our CEO Andrew Simpson how HeartSciences is working to transform the ECG into a far more effective referral tool\nNovember 14, 2022\n\nW...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeart Test Laboratories’ Chairman & CEO, Andrew Simpson, Describes AI-based Technology EKG Test and Next Steps for Commercialization\nOctober 19, ...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeart Test Laboratories, Inc. Announces Pricing of $6.
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board\nMay 7, 2025\n\nMay 7, 2025\n\nSouthlake, TX, May 07, 2025 (GLOBE NEWSW...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement\nNovember 13, 2024\n\nNovember 13, 2024\n\nSouthlake, TX, Nov.
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences and Rutgers University Announce Multi-Year Collaboration to Develop AI-based ECG Algorithms\nDecember 1, 2022\n\n \n\nDecember 1, 20...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences and Rutgers University Announce Multi-Year Collaboration to Develop AI-based ECG Algorithms\nDecember 1, 2022\n\nSouthlake, Texas, D...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Announces Allowance of U.
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Announces Closing of License Agreements with the Icahn School of Medicine at Mount Sinai to Develop and Commercialize AI Cardiovascu...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Announces Conference Participation and Investor Webinar\nAugust 15, 2025\n\nVirtual Events Include Investor Webinar and Presentation...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device\nDecember 15, 2025\n\nSouthlake, TX, Dec.
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Announces Further Expansion of Artificial Intelligence (AI) Patent Portfolio\nAugust 17, 2023\nEuropean Patent Allowed for Quantific...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Announces Further Internationalization of its Patent Portfolio\nFebruary 3, 2023\nGranted Korean Patent for its MyoVista® Wavelet Te...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program\nMay 1, 2025\n\nMay 1, 2025\n\nSouthlake, TX, May ...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Announces Major Milestone with the Issuance of CPT Codes by the American Medical Association for ECG AI Analysis of Cardiac Dysfunct...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Announces Major Milestone with the Issuance of CPT® Codes by the American Medical Association for ECG AI Analysis of Cardiac Dysfunc...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left V...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Announces Results and Adjournment of Annual Shareholder Meeting\nJanuary 18, 2024\n\nSouthlake, TX, Jan.
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Appoints David R.
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Appoints New Scientific Advisory Board Member\nFebruary 1, 2024\n\nSouthlake, TX, Feb.
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Bets Big on AI Amid Surging Heart Disease Deaths\nApril 15, 2024\nFor HeartSciences CEO Andrew Simpson, the pandemic’s fallout only ...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences’ CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025\nMay 20, 2025\n\nMay 20, 2025\n\nSouthlak...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences CEO Invited as Featured Guest on The Big Biz Show, February 7 at 11:45 a.m. Pacific Time\nFebruary 7, 2023\n\nSouthlake, Texas, Feb.
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences CEO to Participate in the Benzinga All Access Event on July 15th\nJuly 13, 2022\n\nSouthlake, Texas, July 13, 2022 (GLOBE NEWSWIRE) ...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences CEO to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on January 25th\nJanuar...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Closes Non-Dilutive Financing to Increase its Cash Runway Ahead of Upcoming FDA Submission\nSeptember 12, 2024\n\nSouthlake, TX, Sep...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Granted European Patent for Proprietary Electrode and Cable Connections for Use with its AI-Based MyoVista® ECG\nOctober 25, 2022\nS...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Granted European Patent for Proprietary Electrode and Cable Connections for Use with its AI-Based MyoVista® ECG\nOctober 25, 2022\nP...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Granted Key Israeli International Patent for its MyoVista® Wavelet Technology Utilizing Artificial Intelligence (AI) for Early Detec...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Granted U.
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences (HSCS) CEO Andrew Simpson Big Biz Show Interview – No Current Frontline Medical Device for Heart Disease Screening\nMay 4, 2023\n\nE...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences ($HSCS) Look To Dominate $25 Billion AI ECG Industry\nApril 30, 2024\nBy Tom White, Benzinga Contributor\n\nIt’s unsurprising to rev...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Inc.
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Issues Investor Update Highlighting Recent Key Achievements and Positive Developments\nOctober 19, 2023\n\nEntered into Transformati...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartsciences’ Myovista AI ECG cost-effectively stratifies cardiac risk, study shows\nNovember 11, 2022\nBy Meg Bryant\n\nHeart Test Laboratories ...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences’ MyoVista® Technology Used to Develop AI-ECG Algorithm to Identify Patients at High-Risk of Major Adverse Cardiovascular Events Hear...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences’ MyoVista® Technology Used to Develop AI-ECG Algorithm to Identify Patients at High-Risk of Major Adverse Cardiovascular Events\nNov...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences’ MyoVista Technology Used to Develop AI-ECG Algorithm to Identify Patients\nNovember 14, 2022\n\na day ago–#artificialintelligence \...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences MyoVista wavECG Technology presented at the UN General Assembly 4th Annual International Digital Health Symposium in New York City!
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences’ MyoVista® wavECGTM Selected for Heart Screening of Irish Garda National Police Officers\nNovember 13, 2023\n\nSouthlake, Texas, Nov...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences’ MyoVista® wavECGTM Selected to be used in Irish Heart Screening Evaluation\nAugust 24, 2023\n\nSouthlake, TX, Aug.
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Named as a Top 10 Healthcare Artificial Intelligence Solutions Provider 2023 by Healthcare Tech Outlook Magazine\nMay 17, 2023\n\nSo...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Named as a Top 10 MedTech Startup 2022 by MedTech Outlook Magazine\nOctober 20, 2022\n\nSouthlake, Texas, Oct.
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Named Electrocardiography Advancement Specialists of the Year 2023 – USA in the Global Health & Pharma Excellence Awards\nSeptember ...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Provides Business Update and Reports First Quarter Fiscal 2023 Financial Results\nSeptember 13, 2022\n\nNearing Completion of Patien...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results\nSeptember 12, 2024\n\nSouthlake, TX, Sept.
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results\nSeptember 11, 2025\n\nHeartSciences | Press Rel...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Provides Business Update and Reports Fiscal 2023 Financial Results\nJuly 19, 2023\n\nSouthlake, Texas, July 19, 2023 (GLOBE NEWSWIRE...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results\nJuly 30, 2024\n\nSouthlake, TX, July 29, 2024 (GLOBE NEWSWIRE) —...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results\nJuly 29, 2025\n\nSouthlake, TX, July 24, 2025 (GLOBE NEWSWIRE) —...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Provides Business Update and Reports Second Quarter Fiscal 2023 Financial Results\nDecember 16, 2022\nPatient Enrollment Close to Co...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results\nDecember 16, 2024\n\nDecember 16, 2024\n\nSouthla...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Provides Business Update and Reports Third Quarter Fiscal 2023 Financial Results\nMarch 16, 2023\n\nSouthlake, Texas, March 16, 2023...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results\nMarch 13, 2025\n\nMarch 13, 2025\n\nSouthlake, TX,...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Provides Corporate Update and Reports Fiscal 2022 Financial Results\nAugust 3, 2022\n\nMyoVista FDA De Novo Resubmission Expected in...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Pumps Life into Assessing Diastolic Dysfunction with New AI Patent\nSeptember 22, 2022\nSouthlake-based HeartSciences, which closed ...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Pumps Life into Assessing Diastolic Dysfunction with New AI Patent\nSeptember 26, 2022\n\nHeartSciences Pumps Life into Assessing Di...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis\nJune 4, 2025\n\nJ...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Receives FDA Confirmation for 510(k) Clearance Pathway\nDecember 5, 2023\n\nSouthlake, TX, Dec.
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Receives Two New Patent Allowances, Expanding its International Patent Portfolio\nSeptember 26, 2023\nPatents Cover MyoVista® Wavele...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder Meeting\nJanuary 3, 2024\n\nSouthlake, TX, Jan.
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Reports First Quarter Fiscal 2024 Financial Results\nSeptember 14, 2023\n\nSouthlake, TX, Sept.
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update\nDecember 15, 2025\n\nSouthlake, TX, Dec.
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Reports Second Quarter Fiscal 2024 Financial Results\nDecember 14, 2023\n\nSouthlake, TX, Dec.
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radical...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Signs Definitive Agreements with the Icahn School of Medicine at Mount Sinai to Commercialize Artificial Intelligence Cardiovascular...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Signs Distribution Agreement with FJ Medical, Denmark\nAugust 31, 2023\n\nSouthlake, TX, Aug.
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Signs Distribution Agreement with MedPhy Technologies, Mumbai, India\nSeptember 7, 2023\n\nSouthlake, TX, Sept.
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone\nMay 29, 2025\n\nMay 29, 2025\n\nSouthlake, TX,...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 – Featuring CEO Andrew Simpson\nMay 8, 2025\n\nMay 8, 2025\n\nSouthlake, ...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences to Participate and Showcase the MyoVista at the Inauguration Ceremony of the Center for Innovation at Rutgers Robert Wood Johnson Un...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences to Participate at the Benchmark Discovery One-on-One Investor Conference on December 1, 2022\nNovember 21, 2022\n\nSouthlake, Texas,...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences to Participate at the Inaugural EF Hutton Global Conference\nMay 8, 2023\n\nSouthlake, Texas, May 08, 2023 — Heart Test Laboratories...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit\nOctober 14, 2024\n\nOctober 14, 2024\n\nSouthlake, TX, Oct.
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences to Participate in The Benchmark Company’s Virtual Individual Investor Healthcare Conference\nMay 2, 2023\n\nSouthlake, Texas, May 02...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences to Participate in the Maxim Group Virtual Tech Conference Series: Emerging Growth in A.I.
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences to Present at MicroCap Rodeo’s Windy City Roundup Conference on October 12th\nOctober 6, 2022\n\nSouthlake, Texas, October 6, 2022, ...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences to Present at the 2022 RHK Disruptive Growth Conference on December 5, 2022\nNovember 28, 2022\n\nSouthlake, Texas, Nov.
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences to Present at the Gilmartin Group Emerging Growth Showcase\nSeptember 12, 2023\n\nSouthlake, TX, Sept.
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences to Present at the H.C. Wainwright 24th Annual Global Investment Conference\nSeptember 8, 2022\n\nSouthlake, Texas, Sept.
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences to Present at the LD Micro Main Event XV on October 26th\nOctober 18, 2022\n\nSouthlake, Texas–(October 18, 2022) – Heart Test Labor...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences to Present at the Planet MicroCap Showcase: VEGAS 2023\nApril 17, 2023\n\nSouthlake, Texas, April 17, 2023 — Heart Test Laboratories...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHow AI is Reshaping Diagnostic Tools\nMarch 4, 2024\nHow AI is Reshaping Diagnostic Tools\nIn healthcare, innovation saves lives.
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio\nMay 20, 2024\n\nGranted Indian Patent for its MyoVista® Wavel...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences Regains Compliance with Nasdaq Listing Requirements\nJune 5, 2024\n\nSouthlake, TX, June 04, 2024 (GLOBE NEWSWIRE) — Heart Test Labo...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences and the technology that could save your life\nMay 7, 2024\n\nAI is about to make a big debut in hospitals\n\nPhoto by National Cance...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nInnovation Value Institute Analysis Demonstrates HeartSciences’ MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency\nJuly 26,...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nMyoVista wavECG goes into clinical use at the Naya Imaging Center in Denmark\nJuly 27, 2023\n\nSouthlake, Texas, July 27, 2023 (GLOBE NEWSWIRE) — ...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nNew study reveals HeartSciences’ MyoVista as a breakthrough in cardiac screening\nApril 11, 2024\n\nIn recent news, HeartSciences has made signifi...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nNJ Innovative Center of Clinical Trials Could Spark Future Cardio Medical Breakthroughs\nSeptember 29, 2022\n\nNEW BRUNSWICK — Robert Wood Johnson...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nPart 2 – Big Biz Show TV Interview with HeartSciences (HSCS) CEO Andrew Simpson\nFebruary 13, 2023\n\nA heart attack is not a good way to find out...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nPart 3 – Big Biz Show TV Interview with HeartSciences (HSCS) CEO Andrew Simpson – Radically Increasing the Value of an ECG\nMarch 6, 2023\n\nHeart...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nPart 4 – Big Biz Show TV Interview with HeartSciences (HSCS) CEO Andrew Simpson – 50% of patients find out they have heart disease through an adve...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nPress release: AI-Driven Study Redefines Right Heart Health Assessment With Novel Predictive Model\nJanuary 4, 2024\nPress Release\nAI-Driven Stud...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nRutgers Launches Development Collaboration for AI-Based ECG Algorithms\nDecember 5, 2022\n\nSource: Getty Images\n\nBy Shania Kennedy\n\nDecember ...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nStudy Warns of Significant Increases in Diabetes and Cardiovascular Disease by 2060\nAugust 5, 2022\n\nStudy Warns of Significant Increases in Dia...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nSupercharging the ECG: AI set to Revolutionise the Diagnostic Cardiology Market\nJanuary 22, 2024\n\nSignify Research has just released a deep-div...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nToday Show highlights that AI-ECG is set to change medicine and save lives.\nMarch 4, 2024\n\nExcerpt from the Today Show.
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nTransformation of Diagnostic Cardiology Using AI\nApril 14, 2025\n\nPartho Sengupta MD, DM, FACC, FASE and the transformation of diagnostic cardio...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nView All HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology\nMarch 6, 2024\nSouthlake, TX, March 06, 2024 (GLOBE NE...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nView All HeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunc...
Read More"\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nWe sit at the forefront of a brand new era for ECGs. Sound dramatic? That’s because it is. CEO Andrew Simpson presents.
Read MoreRequest a demo to see how HeartSciences AI-ECG technology can enhance early detection of heart disease in your practice or health system.
Walk through our 23 peer-reviewed publications and clinical validation data.
See the MyoVista Insights cloud platform and device integration in action.
Discuss integration with your clinical workflows and EHR systems.